Literature DB >> 2768203

Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure.

R P Millman1, B S Fogel, M E McNamara, C C Carlisle.   

Abstract

Fifty-five patients with obstructive sleep apnea each completed a Zung Self-Rating Depression Scale (SDS), Twenty-five patients (45%) had SDS scores greater than or equal to 50, consistent with depression. The SDS scores did not correlate with age, the number of respiratory events per hour sleep, antihypertensive medication, or the oxygen saturation baseline or nadir. The group with SDS scores of 50 or greater, however, had 68.0 +/- 8.8 respiratory events per hour compared with 47.9 +/- 4.7 in the group with SDS scores under 50 (p less than .05). Nineteen patients who were treated with nasal continuous positive airway pressure completed a follow-up SDS Inventory. After treatment, the SDS scores fell from 60.5 +/- 1.9 to 44.4 +/- 2.6 (p less than .001) in the 11 patients with baseline elevated scores. The authors conclude that obstructive sleep apnea can produce prominent symptoms of depression that appear to be related to the severity of the underlying apnea; furthermore, treatment of obstructive sleep apnea may result in alleviation of these symptoms in certain patients.

Entities:  

Mesh:

Year:  1989        PMID: 2768203

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  37 in total

Review 1.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

2.  Sleep-disordered breathing: in depression and schizophrenia.

Authors:  Fredric Jaffe; Dimitri Markov; Karl Doghramji
Journal:  Psychiatry (Edgmont)       Date:  2006-07

3.  Dim light at night interacts with intermittent hypoxia to alter cognitive and affective responses.

Authors:  Taryn G Aubrecht; Zachary M Weil; Ulysses J Magalang; Randy J Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-05-08       Impact factor: 3.619

Review 4.  Obstructive sleep apnea and severe mental illness: evolution and consequences.

Authors:  Wei-Chen Lin; John W Winkelman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

5.  Emotional content of dreams in obstructive sleep apnea hypopnea syndrome patients and sleepy snorers attending a sleep-disordered breathing clinic.

Authors:  Samantha Fisher; Keir E Lewis; Iona Bartle; Robin Ghosal; Lois Davies; Mark Blagrove
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

6.  Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment.

Authors:  C Diamanti; E Manali; M Ginieri-Coccossis; K Vougas; K Cholidou; E Markozannes; P Bakakos; I Liappas; M Alchanatis
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

7.  Increased mortality among sleepy snorers: a prospective population based study.

Authors:  E Lindberg; C Janson; K Svärdsudd; T Gislason; J Hetta; G Boman
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

8.  Impact of Sleep-Disordered Breathing Treatment on Patient Reported Outcomes in a Clinic-Based Cohort of Hypertensive Patients.

Authors:  Harneet K Walia; Sandra D Griffith; Nicolas R Thompson; Douglas E Moul; Nancy Foldvary-Schaefer; Reena Mehra
Journal:  J Clin Sleep Med       Date:  2016-10-15       Impact factor: 4.062

9.  Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study.

Authors:  Jana R Cooke; Liat Ayalon; Barton W Palmer; Jose S Loredo; Jody Corey-Bloom; Loki Natarajan; Lianqi Liu; Sonia Ancoli-Israel
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

10.  Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients.

Authors:  Paul M Macey; Mary A Woo; Rajesh Kumar; Rebecca L Cross; Ronald M Harper
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.